Detalles de la búsqueda
1.
Health-related quality of life in patients with newly diagnosed advanced ovarian cancer treated with niraparib vs placebo: Results from the phase 3 randomized PRIMA/ENGOT-OV26/GOG-3012 trial.
Gynecol Oncol
; 184: 168-177, 2024 Feb 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38325276
2.
Lifestyle intervention in ovarian cancer enhanced survival (LIVES) study (NRG/GOG0225): Recruitment, retention and baseline characteristics of a randomized trial of diet and physical activity in ovarian cancer survivors.
Gynecol Oncol
; 170: 11-18, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36608382
3.
The effect of older age on treatment outcomes in women with advanced ovarian cancer receiving chemotherapy: An NRG-Oncology/Gynecologic Oncology Group (GOG-0182-ICON5) ancillary study.
Gynecol Oncol
; 173: 130-137, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37148580
4.
Carboplatin dosing in the treatment of ovarian cancer: An NRG oncology group study.
Gynecol Oncol
; 174: 213-223, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37229879
5.
Beyond Sedlis-A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis.
Gynecol Oncol
; 162(3): 532-538, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34217544
6.
Long term survival outcomes of stage I mucinous ovarian cancer - A clinical calculator predictive of chemotherapy benefit.
Gynecol Oncol
; 159(1): 118-128, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32828578
7.
Predictive modeling for determination of microscopic residual disease at primary cytoreduction: An NRG Oncology/Gynecologic Oncology Group 182 Study.
Gynecol Oncol
; 148(1): 49-55, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29174555
8.
Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.
Gynecol Oncol
; 147(2): 396-401, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28935272
9.
Association between hypoalbuminemia and surgical site infection in vulvar cancers.
Gynecol Oncol
; 142(3): 435-9, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27394633
10.
A phase II study of paclitaxel for the treatment of ovarian stromal tumors: An NRG Oncology/ Gynecologic Oncology Group Study.
Gynecol Oncol
; 140(1): 48-52, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26616224
11.
Adjuvant Treatment and Clinical Trials in Elderly Patients With Endometrial Cancer: A Time for Change?
Int J Gynecol Cancer
; 26(2): 282-9, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26745698
12.
Obesity is associated with worse quality of life in women with gynecologic malignancies: an opportunity to improve patient-centered outcomes.
Cancer
; 121(3): 395-402, 2015 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25250951
13.
Patient and physician factors associated with participation in cervical and uterine cancer trials: an NRG/GOG247 study.
Gynecol Oncol
; 138(1): 101-8, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25937529
14.
Efficacy and safety of bevacizumab in recurrent sex cord-stromal ovarian tumors: results of a phase 2 trial of the Gynecologic Oncology Group.
Cancer
; 120(3): 344-51, 2014 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24166194
15.
Temsirolimus with or without megestrol acetate and tamoxifen for endometrial cancer: a gynecologic oncology group study.
Gynecol Oncol
; 132(3): 585-92, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24456823
16.
Topical 5-fluorouracil for treatment of cervical intraepithelial neoplasia 2: a randomized controlled trial.
Am J Obstet Gynecol
; 210(4): 314.e1-314.e8, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24384495
17.
Translational studies of phenotypic probes for the mononuclear phagocyte system and liposomal pharmacology.
J Pharmacol Exp Ther
; 347(3): 599-606, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24042160
18.
Recurrence-free and 5-year survival following robotic-assisted surgical staging for endometrial carcinoma.
Gynecol Oncol
; 129(1): 49-53, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23262377
19.
Outpatient end of life discussions shorten hospital admissions in gynecologic oncology patients.
Gynecol Oncol
; 130(1): 152-5, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23542684
20.
Predictors of reduced relative dose intensity and its relationship to mortality in women receiving multi-agent chemotherapy for epithelial ovarian cancer.
Gynecol Oncol
; 129(1): 74-80, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23262376